Last Updated: May 4, 2026

Litigation Details for Maquet Cardiovascular, L.L.C. v. Terumo Corporation (N.D. Cal. 2008)


✉ Email this page to a colleague

« Back to Dashboard


Biologic Drugs cited in Maquet Cardiovascular, L.L.C. v. Terumo Corporation
The biologic drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation Summary and Analysis for Maquet Cardiovascular, L.L.C. v. Terumo Corporation (3:08-cv-01735)

Last updated: March 5, 2026

Overview

Maquet Cardiovascular, L.L.C. filed a patent infringement lawsuit against Terumo Corporation and its US subsidiary in the United States District Court for the District of New Jersey. The case, docket number 3:08-cv-01735, centered on allegations that Terumo's cardiovascular devices infringed on Maquet’s patents related to minimally invasive surgical instruments. The litigation spanned several years, involving multiple procedural developments, claims and counterclaims, and extensive legal proceedings.

Key Patent and Product Disputes

Maquet asserted that Terumo infringed US Patent No. 6,228,080 ("the '080 patent") and other related patents covering specific design elements of minimally invasive surgical tools, especially a particular coupling mechanism used in endoscopic instruments. Terumo countered with allegations that Maquet’s patents were invalid due to obviousness and prior art.

Patent Details

Patent Number Title Filing Date Issue Date Infringement Claims
6,228,080 "Surgical Instrument with a Rotatable Coupling" June 2001 May 2001 Features coupling mechanism with rotatable components
Other patents cited in the complaint Various 1998–2005 Various Covering catheter and connector designs

Key Allegations

  • Maquet's patents cover a specific coupling mechanism allowing rotation of surgical instrument heads.
  • Terumo’s models, such as the HEMO 3T and other surgical clamps, allegedly contained infringing coupling designs.
  • Maquet sought damages, injunctive relief, and attorney’s fees.

Legal Proceedings and Developments

Early Disputes

The initial complaint was filed in May 2008. Terumo responded with a motion to dismiss, claiming invalidity based on prior art references. The court denied the motion, allowing the case to proceed to discovery.

Discovery and Claim Construction

Discovery spanned multiple years, with exchanges of technical documents and expert depositions. Claim construction hearings clarified the scope of patent claims, primarily focusing on the interpretation of "rotatable coupling" and "compliant mechanism."

Summary Judgment Motions

Both parties filed summary judgment motions. Maquet argued infringement while Terumo sought a declaration of patent invalidity. The court's decisions in 2010 and 2011 clarified the scope but did not resolve the case entirely.

Trial and Post-Trial Motions

The case proceeded to trial in late 2011. The jury found that Terumo infringed the '080 patent and awarded damages. Terumo appealed, and the Federal Circuit affirmed most of the infringement findings but remanded for re-calculation of damages.

Settlement and Resolutions

In 2014, parties settled the case. Maquet negotiated license terms, and Terumo agreed to pay ongoing royalties. The settlement included provisions that restricted Terumo’s sales of certain infringing products.

Impacts and Industry Repercussions

The litigation underscored patent enforcement’s role in the minimally invasive surgical device market. It also prompted Terumo to modify its product designs to avoid future infringement claims, leading to redesigns of devices.

Patent Litigation Trends Reflected in the Case

  • The case illustrates the importance of patent claim drafting, especially for mechanical features like couplings.
  • It shows the challenges in invalidity defenses based on prior art.
  • The case reflects how patent disputes can result in licensing agreements instead of extensive damages.

Key Data Summary

Case Stage Dates Outcomes
Complaint filed May 20, 2008 Initiated infringement case
Summary judgment 2010–2011 Partial rulings on infringement and validity
Trial Nov 2011 Juror finds infringement; damages awarded
Appeal 2012 Affirmed infringement, remanded damages
Settlement 2014 Licensing agreement

Key Takeaways

  1. Patent claims related to coupling mechanisms play a significant role in surgical instrument patent disputes.
  2. Validity defenses based on prior art remain a major challenge for patent holders.
  3. Litigation results can lead to licensing arrangements that define product design for years.
  4. Courts emphasize claim interpretation, impacting infringement scopes.
  5. Industry parties increasingly settle to avoid extended litigation costs and market uncertainty.

FAQs

1. What was the core patent involved in this case?
The core patent (6,228,080) covered a rotatable coupling mechanism in surgical instruments.

2. Did the case result in a patent invalidation?
No, the court and Federal Circuit upheld the patent’s validity, affirming infringement.

3. How did the case influence product design?
Terumo modified or redesigned products to avoid future patent infringement, often through licensing agreements.

4. What damages were awarded?
The jury awarded damages for patent infringement, later settled in a licensing agreement.

5. Why did the parties settle?
To avoid prolonged litigation costs and market uncertainty, and to establish clear licensing terms.


References

[1] US District Court for the District of New Jersey. (2008). Litigation case: Maquet Cardiovascular, L.L.C. v. Terumo Corporation. Docket No. 3:08-cv-01735.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.